Abstract 5718: Cbx5 as a potential target to enhance immunotherapy in small cell lung cancer
Hong Cao, Yiting Li, Jiajia Gu, Yuan Hao et autres
Abstract Small cell lung cancer (SCLC) is a highly aggressive neuroendocrine carcinoma with a very poor prognosis and accounts for approximately 15% of all lung cancers. Although immunotherapy is now a key component of standard care for SCLC, the clinical benefits remain …
us (code pays fourni par la source)